AR and hepatocellular carcinoma: These findings provide a rationale for targeting AR/AR-SVs in HCC with an agent like niclosamide, and, consistent with its effects on the AR protein, niclosamide decreased the invasion of AR-SV(±) SNU475 cells (Figure S3B).